Zobrazeno 1 - 10
of 401
pro vyhledávání: '"G. Chau"'
Autor:
A. Sanchez, G. Chau, S. Ferretti, F. Babinec, R. Colazo, J. De Durana, D. Estelrich, M. Zappa
Publikováno v:
Semiárida, Vol 12, Iss 1 (2020)
El presente trabajo contiene información que permite caracterizar la forma en que se desenvuelve el sector productor de leche de la Provincia de La Pampa, base para desarrollar una estrategia de Extensión. La superficie de los predios que integran
Externí odkaz:
https://doaj.org/article/8435d8859af64ff086d49112d35544c8
Autor:
Justine A. Barletta, Steven D. Gilday, Michelle Afkhami, Diana Bell, Theresa Bocklage, Pierre Boisselier, Nicole G. Chau, Nicole A. Cipriani, Valerie Costes-Martineau, Ronald A. Ghossein, Hans J. Hertzler, Alan M. Kramer, Sewanti Limaye, Carlos A. Lopez, Tony L. Ng, Annikka Weissferdt, Bin Xu, Songlin Zhang, Christopher A. French
Publikováno v:
American Journal of Surgical Pathology. 46:1706-1715
NUT carcinoma (NC) is a rare subtype of squamous cell carcinoma defined by NUTM1 rearrangements encoding NUT fusion oncoproteins (the most frequent fusion partner being BRD4 ) that carries a very poor prognosis, with most patients dying in under 1 ye
Publikováno v:
ASPET 2023 Annual Meeting Abstract - Cancer Pharmacology.
Autor:
Jonathan D. Schoenfeld, Glenn Dranoff, Scott J. Rodig, F. Stephen Hodi, Gordon J. Freeman, Adel El-Naggar, Peter Hammerman, Mariano Severgnini, Robert I. Haddad, Nicole G. Chau, Xiaoyun Liao, Evisa Gjini, Vishwajith Sridharan
Genes associated with poor immune infiltration and seromic profiles
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ed88afef78d5bc1437f32d2c5ca1ad7
https://doi.org/10.1158/2326-6066.22538044
https://doi.org/10.1158/2326-6066.22538044
Autor:
Jonathan D. Schoenfeld, Glenn Dranoff, Scott J. Rodig, F. Stephen Hodi, Gordon J. Freeman, Adel El-Naggar, Peter Hammerman, Mariano Severgnini, Robert I. Haddad, Nicole G. Chau, Xiaoyun Liao, Evisa Gjini, Vishwajith Sridharan
Adenoid cystic carcinoma (ACC) is among the most lethal salivary gland tumors, with no treatments for metastatic disease that prolong survival. We examined tissue from 28 primary and metastatic ACC deposits obtained from 21 patients for infiltrating
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f3629fc41031f04734b0b95ae55edc42
https://doi.org/10.1158/2326-6066.c.6548647.v1
https://doi.org/10.1158/2326-6066.c.6548647.v1
Autor:
Jochen H. Lorch, Pasi A. Jänne, Stephanie L. Lee, Ellen Marqusee, Matthew Nehs, Tom Thomas, Krystof Misiwkeiwicz, Francis D. Moore, Erik K. Alexander, Sewanti A. Limaye, Anne O'Neill, Guilherme Rabinowits, Maria E. Cabanillas, Stefan Kraft, Robert I. Haddad, Antonio Calles, Justine A. Barletta, Lori J. Wirth, Nicole G. Chau, Naifa L. Busaidy, Glenn J. Hanna
Supplementary Table S2. Clinical response and outcomes to everolimus in patients with advanced differentiated thyroid cancers by histologic subgroup
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3955f6964c6f6bbf2604945400a44ae5
https://doi.org/10.1158/1078-0432.22465415.v1
https://doi.org/10.1158/1078-0432.22465415.v1
Autor:
Peter S. Hammerman, Robert I. Haddad, Geoffrey I. Shapiro, Neal I. Lindeman, Jeffrey F. Krane, Tyler Haddad, Hailey Becker, Tom Thomas, Laura A. Goguen, Don J. Annino, Jonathan D. Schoenfeld, Danielle N. Margalit, Roy B. Tishler, Jochen H. Lorch, Guilherme Rabinowits, Vickie Y. Jo, Yvonne Y. Li, Nicole G. Chau
Supplementary Figure 6: Presence of GATA4 Amplification is Associated with Overall Survival Across the Oncopanel Cohort (n=109). Supplementary Figure 7: Presence of PIK3CA Tier1/2 Mutations Alone, without Considering Copy Number Amplifications, is no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35459b16cd16f069c9e4f8b5baca3d2b
https://doi.org/10.1158/1078-0432.22459715.v1
https://doi.org/10.1158/1078-0432.22459715.v1
Autor:
Peter S. Hammerman, Robert I. Haddad, Geoffrey I. Shapiro, Neal I. Lindeman, Jeffrey F. Krane, Tyler Haddad, Hailey Becker, Tom Thomas, Laura A. Goguen, Don J. Annino, Jonathan D. Schoenfeld, Danielle N. Margalit, Roy B. Tishler, Jochen H. Lorch, Guilherme Rabinowits, Vickie Y. Jo, Yvonne Y. Li, Nicole G. Chau
Correlation with Number of Alterations per Sample and Progression-Free Survival.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::093c7585519349baa8640522559f2c45
https://doi.org/10.1158/1078-0432.22459730
https://doi.org/10.1158/1078-0432.22459730
Autor:
Peter S. Hammerman, Robert I. Haddad, Geoffrey I. Shapiro, Neal I. Lindeman, Jeffrey F. Krane, Tyler Haddad, Hailey Becker, Tom Thomas, Laura A. Goguen, Don J. Annino, Jonathan D. Schoenfeld, Danielle N. Margalit, Roy B. Tishler, Jochen H. Lorch, Guilherme Rabinowits, Vickie Y. Jo, Yvonne Y. Li, Nicole G. Chau
Presence of MCL1 Amplification is Associated with Progression-Free Survival Across the Oncopanel Cohort (n=109).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bd3137f7e045e7be1080aa49ec3842a
https://doi.org/10.1158/1078-0432.22459724.v1
https://doi.org/10.1158/1078-0432.22459724.v1
Autor:
Jochen H. Lorch, Pasi A. Jänne, Stephanie L. Lee, Ellen Marqusee, Matthew Nehs, Tom Thomas, Krystof Misiwkeiwicz, Francis D. Moore, Erik K. Alexander, Sewanti A. Limaye, Anne O'Neill, Guilherme Rabinowits, Maria E. Cabanillas, Stefan Kraft, Robert I. Haddad, Antonio Calles, Justine A. Barletta, Lori J. Wirth, Nicole G. Chau, Naifa L. Busaidy, Glenn J. Hanna
Purpose: Targeting mutations leading to PI3K/mTOR/Akt activation are of interest in thyroid cancer. We evaluated the efficacy of everolimus in aggressive, radioactive iodine–refractory (RAIR) thyroid cancer and correlated tumor mutational profiling
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a564e905d144c00cdb9917bc4b2bfca
https://doi.org/10.1158/1078-0432.c.6526016
https://doi.org/10.1158/1078-0432.c.6526016